The p53 tumor suppressor gene


© David Olle
Articles in this Topic    Discussions in this Topic
Page 2
1. Gene therapy

I have previously discussed gene therapy in this series. It basically involves restoring the functioning of a defective gene by the addition of a normal gene into the DNA structure. However, the concept has proven very difficult to apply in practice, particularly in terms of delivery. Roth and Swisher 6 attached normal p53 gene to a adenovirus and injected it directly into tumors. The results of the studies indicated tumor regression in both laboratory animals as well as humans. Preclinical studies indicate that chemotherapeutic agents such as cisplatin and etoposide can act synergistically with the gene therapy to enhance the effect in shrinking the tumors.

2. Maintaining structural integrity of the mutated p53 molecule The functioning of p53 protein is completely dependent upon maintaining the correct three-dimensional conformation of the molecule. Pfizer research 3 has conducted studies in which they inserted small synthetic molecules into the DNA binding region of mutated p53 protein. This technique stabilized the active conformation of newly synthesized mutated p53, but could not rescue p53 if it had already lost the active conformation. With time this active fraction accumulates, and has the ability to inhibit tumor growth in mice.

3. Dietary components Green tea has long been shown to have a protective effect against cancer .The active component is epigallocatechin-3-gallate. Likewise, a component of grapes known as resveratrol has been shown to have a protective effect. Studies have shown that these components activate p53, leading to cell-cycle arrest and apoptosis.

A physiological metabolite of Vitamin A known as retinoic acid is widely used for the prevention of non-melanoma skin cancer. A study 5 has shown that retinoic acid acts by increasing the expression of p53 in epidermal cells.

Finally, several selenium compounds (selenomethionine, sodium selenite, methyl-seleninic acid) act by different mechanisms to regulate the activities of p53, including DNA repair or apoptosis. 7

References

1. Bode A, and Dong Z. Post-translational modification of p53 in tumorigenesis. Nature Reviews Cancer. 2004 Oct; 4 (10): 793-805.

2. Culotta E and Koshland D Jr. p53 sweeps through cancer research. Science. 1993 Dec 24; 262: 1958-1961.

3. Foster B, Coffey H, et al. Pharmacological rescue of mutant p53 conformation and function. Science. 1999 Dec 24; 286 (5449): 2507-2510.

4. Harris C and Hollstein M. Clinical implications of the p53 tumor-suppressor gene. New England J Medicine 1993 Oct 28; 329: 1318-1327.

5. Mrass P, Rendl M, et al. Retinoic acid increases the expression of p53 and proapoptotic caspases and sensitizes keratinocytes to apoptosis: a possible explanation for tumor preventive action of retinoids. Cancer Research 2004 Sep 15; 64 (18): 6524-6.

Go To Page: 1 2 3


Post this Article to facebook Add this Article to del.icio.us! Digg this Article furl this Article Add this Article to Reddit Add this Article to Technorati Add this Article to Newsvine Add this Article to Windows Live Add this Article to Yahoo Add this Article to StumbleUpon Add this Article to BlinkLists Add this Article to Spurl Add this Article to Google Add this Article to Ask Add this Article to Squidoo